LIVE QUOTE |
Quotes delayed 15+ min. |
- Home Prices Decline Further In Most Parts of US
- Ponzi Proceeds: Bidding on Madoff's Toys
- Jobless Rate to Hit 10.5%, Keeping Fed in Box: Poll
- Credit Card Firms Squeeze Customers as Rules Loom
- Trustee Seeks Billions for Madoff Investors
- Quiz: Do You Know Your Coca-Cola Myths?
- New Lows for Stocks Next Year: Equities Bear
- 'Peak Oil' Closer Than IEA Forecasts Show: Report
- Mortgage Modification Program Shows Improvement
- If Mickey Mouse Has to Change—What Does That Say About You?
- Nov. 10: S&P Stocks Trading at New 52-Week Highs
- Passive Job Search Strategies
- Back Off, Regulators!
- America Is On Sale
- Warren Buffett and the Crisis: 'Brilliant Moves Interspersed with Some Surprising Errors'
- Schork Oil Outlook: More Strength in Crude
- Chrysler Makes Smart Call Staying Unplugged—For Now
- Your Next Move: Thriving and Managing in Limbo
- Venezuela moves toward control of coffee companies
- Harbin posts $1.9M loss for 3rd quarter
- Hovnanian to get tax benefit in 1Q, 2Q of 2010
- Prosecutors: SC trio promised unrealistic returns
- Cheesecake Factory to pay $345K in harassment case
- Cumberland 3Q profit rose on Caldolor sales
- Priceline.com shares jump on strong outlook
- Okla.'s Langston Univ. receives $800,000 fed grant
- Qiagen 3Q profit jumps on boost in test sales
Text Size 
WASHINGTON - The Justice Department on Monday accused Wyeth, one of the nation’s biggest drugmakers, of cheating Medicaid programs out of hundreds of millions of dollars by overcharging for a stomach acid drug.
The Justice Department and more than a dozen states have joined in two whistleblower lawsuits against the Madison, N.J.-based drug company filed in federal court in Massachusetts.
The court papers claim that between 2000 and 2006, Wyeth offered steep discounts to thousands of hospitals for two versions of Protonix, a drug that suppresses stomach acid.
By law, manufacturers of brand-name drugs are required to offer the same rebates to state Medicaid programs that they provide to other customers.
The government claims the maneuver helped the company avoid paying hundreds of millions of dollars in rebates to Medicaid, a health care program for the poor that is funded by state and federal money.
“By offering massive discounts to hospitals, but then hiding that information from the Medicaid program, we believe Wyeth caused Medicaid programs throughout the country to pay much more for these drugs than they should have,” Assistant Attorney General Tony West said in a statement.
In court papers, the government accused the drug company of bundling the intravenous version of Protonix with the oral version in sales packages to hospitals, in the hopes of making more money in the lucrative outpatient market.
Wyeth defended its pricing plan.
“The company believes that it’s pricing calculations were correct and intends to defend itself vigorously in these actions,” said Doug Petkus, a Wyeth spokesman.
The states joining the lawsuit are California, Delaware, Florida, Illinois, Indiana, Louisiana, Massachusetts, New York, Michigan, Nevada, New Hampshire, Tennessee, Texas, Virginia and Wisconsin, as well as the District of Columbia.
New York-based drugmaker Pfizer Inc. is in the process of acquiring Wyeth for more than $60 billion in a deal expected to close later this year.
Print
Email
- From politicians to CEOs to companies, here's your chance to vote for the winners and losers of 2009.
- What’s powering your microwave, fridge and computer? Part of it is fuel from Russian nuclear weapons. The NYT reports.
- With prices well below peak, gems could add some sparkle to your investments.
- Do free market libertarians really believe what they say about ethics and shareholder value? The Big Money takes a look.
- On the anniversary of the fall of the Berlin Wall, many in the former Eastern Bloc recall communism fondly.
- The opening of a virtual pet store in “World of Warcraft” could prove a cash bonanza for Activision-Blizzard.
Data is a real-time snapshot *Data is delayed at least 15 minutes